Stifel Financial Corp grew its stake in Agilent Technologies, Inc. (NYSE:A) by 17.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,768 shares of the medical research company’s stock after buying an additional 9,972 shares during the period. Stifel Financial Corp’s holdings in Agilent Technologies were worth $4,412,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Jennison Associates LLC acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $212,000. Commerce Bank acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $1,242,000. Delta Lloyd Asset Management N.V. acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $2,026,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Agilent Technologies by 9.9% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after buying an additional 90,317 shares during the period. Finally, Prudential Financial Inc. increased its stake in shares of Agilent Technologies by 2.5% in the second quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after buying an additional 11,020 shares during the period.
Several equities research analysts recently commented on the company. Goldman Sachs Group restated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research report on Tuesday, September 26th. Cowen restated a “hold” rating and set a $65.00 target price on shares of Agilent Technologies in a research report on Thursday, September 28th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research report on Tuesday, October 10th. Robert W. Baird restated a “buy” rating and set a $70.00 target price on shares of Agilent Technologies in a research report on Friday, October 20th. Finally, Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $68.34.
Agilent Technologies, Inc. (A) opened at $67.61 on Friday. The stock has a market capitalization of $21,758.79, a P/E ratio of 28.53, a price-to-earnings-growth ratio of 2.04 and a beta of 1.27. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies, Inc. has a fifty-two week low of $45.36 and a fifty-two week high of $70.93.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 earnings per share. equities analysts expect that Agilent Technologies, Inc. will post 2.58 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $0.60 annualized dividend and a yield of 0.88%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is presently 25.24%.
ILLEGAL ACTIVITY WARNING: This article was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2017/12/17/stifel-financial-corp-buys-9972-shares-of-agilent-technologies-inc-a.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.